Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.
Clinical trial NCT03220230 · COMPLETED
Trial details
- NCT number
- NCT03220230
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-07-06
- Primary completion
- 2018-10-30
- Enrollment
- 4240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.